also known bay selective orally active erÎ² agonist development bayer healthcare ag treatment vasomotor reached phase ii clinical trials prior discontinuation development terminated drug article relating genitourinary system stub help wikipedia expanding drug article relating nervous system stub help wikipedia expanding